Meeting Organocatalysis with Drug Discovery: Asymmetric Synthesis of 3,3′-Spirooxindoles Fused with Tetrahydrothiopyrans As Novel P53-Mdm2 Inhibitors

Shengzheng Wang,Yan Jiang,Shanchao Wu,Guoqiang Dong,Zhenyuan Miao,Wannian Zhang,Chunquan Sheng
DOI: https://doi.org/10.1021/acs.orglett.6b00155
IF: 5.2
2016-01-01
Organic Letters
Abstract:An organocatalytic enantioselective Michael-Michael cascade reaction is developed for the synthesis of chiral spirotetrahydrothiopyrans. This highly functionalized scaffold was assembled in moderate to good yield (55-74%) and excellent diastereo- and enantioselectivities (>30:1 dr, ≥ 99% ee) with the creation of four consecutive stereogenic centers. The novel spiro-oxindole scaffold is validated as a new class of p53-MDM2 protein-protein interaction inhibitors with good antitumor activity.
What problem does this paper attempt to address?